DarioHealth Corp. (NASDAQ:DRIO) will post its quarterly earnings results before the market opens on Monday, August 14th.

DarioHealth Corp. (NASDAQ:DRIO) last posted its quarterly earnings data on Monday, May 15th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of ($0.47) by $0.92. DarioHealth Corp. had a negative return on equity of 413.18% and a negative net margin of 199.14%. The business had revenue of $1.01 million for the quarter. On average, analysts expect DarioHealth Corp. to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DarioHealth Corp. (NASDAQ:DRIO) traded up 14.63% during trading on Friday, reaching $2.39. The company had a trading volume of 16,560 shares. The firm’s market capitalization is $22.90 million. DarioHealth Corp. has a 12-month low of $1.90 and a 12-month high of $4.70. The firm’s 50 day moving average price is $2.50 and its 200 day moving average price is $3.03.

WARNING: This story was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.dailypolitical.com/2017/08/12/dariohealth-corp-nasdaqdrio-scheduled-to-post-earnings-on-monday.html.

DarioHealth Corp. Company Profile

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter.

Earnings History for DarioHealth Corp. (NASDAQ:DRIO)

Receive News & Ratings for DarioHealth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.